In vivo tracking of plasmid DNA/mRNA: A novel labelling precursor for 89Zr positron emission tomography

Naohiro Aoyama1, Sadaaki Kimura1, Toshiyuki Matsui1

  • 1Astellas Pharma Inc., 21, Miyukigaoka, Tsukuba-shi, Ibaraki 305-8585, Japan.

Insights

We created a new method to label plasmid DNA (pDNA) with the PET imaging radioisotope 89Zr. This 89Zr-labeled pDNA maintains gene expression and allows for biodistribution studies, also applicable to mRNA.

Area of Science:

  • Biomedical imaging
  • Molecular biology
  • Radiochemistry

Background:

  • Plasmid DNA (pDNA) is crucial for gene therapy and research.
  • Non-invasive imaging of pDNA delivery is essential for therapeutic development.
  • Current labeling methods for pDNA may affect its biological activity.

Purpose of the Study:

  • To develop a novel labeling precursor for 89Zr-based PET imaging of pDNA.
  • To evaluate the gene expression and biodistribution of 89Zr-labeled pDNA.
  • To assess the applicability of this labeling method to mRNA.

Main Methods:

  • Synthesis of a novel labeling precursor, Fe-DFO-5.
  • Radiolabeling of plasmid DNA (pDNA) with 89Zr.
  • In vitro gene expression assays.
  • In vivo biodistribution studies in mice.
  • Application of the labeling method to mRNA.

Main Results:

  • Successful development of the Fe-DFO-5 precursor for 89Zr labeling.
  • 89Zr-labeled pDNA demonstrated comparable gene expression to unlabeled pDNA.
  • Biodistribution of 89Zr-labeled pDNA was successfully evaluated after local and systemic administration.
  • The labeling technique was also effective for mRNA.

Conclusions:

  • Fe-DFO-5 is a viable precursor for 89Zr labeling of pDNA for PET imaging.
  • 89Zr-labeled pDNA is suitable for gene expression studies and biodistribution analysis.
  • This novel labeling approach holds promise for imaging nucleic acid delivery in vivo, including mRNA.

Related Concept Videos